Comments

Ayala Pharmaceuticals Insider Trading Activity

ADXSOTCEM
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$0.0510
Last update: Dec 12, 3:07 PM
OverviewNewsEarningsAnalyst Ratings

Insider Trades

Short Interest

Ayala Pharmaceuticals Insider Trading Activity | OTC:ADXS | Benzinga

Track the latest Ayala Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Ayala Pharmaceuticals stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Ayala Pharmaceuticals Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Ayala Pharmaceuticals Inc

Shares Outstanding
42.594M
Institutional Percentage Held
0.02%
Oct 31, 2023Israel Biotech Fund I LPIsrael Biotech Fund II LPIsrael Biotech Fund GP Partners LPIsrael Biotech Fund GP Partners II LPIBF Management Ltd10% OWNER1.32M$0.00$0.00BUY∞1.09MOct 18View
Mar 16, 2020Roni Appel—-3.00K$0.57-$1.70KSELL-22.26%10.48KMar 11 - Mar 13View
Apr 11, 2019Roni AppelDIRECTOR3.00K$3.80$11.39KBUY28.64%13.48KApr 10View
Nov 07, 2018Robert PetitCHIEF SCIENTIFIC OFFICER-3.96K$0.58-$2.30KSELL-1.69%231.21KNov 05View
Nov 05, 2018Robert PetitCHIEF SCIENTIFIC OFFICER-8.49K$0.56-$4.75KSELL-3.48%235.17KNov 02View
Sep 13, 2018Roni AppelDIRECTOR33.33K$1.20$40.00KBUY26.92%157.14KSep 11View
Apr 03, 2018Robert PetitCHIEF SCIENTIFIC OFFICER-1.08K$1.66-$1.68KSELL-0.48%223.50KMar 29 - Apr 02View
Feb 02, 2018Anthony LombardoINTERIM CEO-32.00$2.93-$93.76SELL-0.03%92.90KFeb 02View
Jan 03, 2018Sara BonsteinCHIEF FINANCIAL OFFICER-4.75K$3.01-$15.27KSELL-2.08%224.01KDec 29 - Jan 03View
Nov 06, 2017Robert PetitCHIEF SCIENTIFIC OFFICER-3.72K$3.30-$12.29KSELL-1.66%220.92KNov 06View
Nov 06, 2017Sara BonsteinCHIEF FINANCIAL OFFICER-3.86K$3.30-$12.74KSELL-1.67%227.91KNov 06View
Nov 02, 2017Anthony LombardoINTERIM CEO-24.00$3.19-$76.56SELL-0.03%92.94KNov 02View
Nov 02, 2017Robert PetitCHIEF SCIENTIFIC OFFICER-12.19K$3.29-$38.80KSELL-5.15%224.64KOct 31 - Nov 02View
Nov 02, 2017Sara BonsteinCHIEF FINANCIAL OFFICER-12.36K$3.29-$39.33KSELL-5.06%231.77KOct 31 - Nov 02View
Oct 12, 2017ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER-600.00K$4.30-$2.58MSELL-12.77%4.10MOct 11View
Sep 26, 2017ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER-1.24M$4.42-$5.47MSELL-20.87%4.70MSep 22 - Sep 26View
Apr 03, 2017Petit RobertCHIEF SCIENTIFIC OFFICER-2.23K$8.21-$18.43KSELL-1.83%119.60KMar 31View
Jan 03, 2017Sara BonsteinCHIEF FINANCIAL OFFICER44.72K$7.26-$38.98KGRANT54.56%126.68KDec 30View
Dec 21, 2016Thomas MckearnDIRECTOR-12.32K$8.08-$99.51KSELL-15.00%69.80KDec 20View
Nov 02, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-2.63K$8.20-$21.95KSELL-2.13%120.74KOct 31 - Nov 02View
Nov 02, 2016Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.00K$8.20-$66.65KSELL-2.64%294.66KOct 31 - Nov 02View
Oct 26, 2016Gregory MayesCHIEF BUSINESS OFFICER-19.16K$8.23-$157.70KSELL-15.67%103.09KOct 25View
Aug 10, 2016Richard BermanDIRECTOR-33.76K$15.42-$520.75KSELL-39.99%50.67KAug 08 - Aug 09View
Aug 10, 2016David SidranskyDIRECTOR-22.81K$15.01-$342.35KSELL-22.11%80.36KAug 08 - Aug 09View
May 13, 2016Thomas MckearnDIRECTOR-4.10K$7.45-$30.55KSELL-4.76%82.12KMay 13View
May 02, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-2.61K$7.63-$19.59KSELL-2.05%125.12KApr 29 - May 02View
May 02, 2016Daniel O'ConnorCHIEF EXECUTIVE OFFICER-7.62K$7.63-$57.11KSELL-2.42%307.82KApr 29 - May 02View
Apr 01, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-3.18K$9.08-$29.06KSELL-2.43%127.73KMar 31View
Mar 18, 2016Thomas MckearnDIRECTOR-14.00K$8.25-$115.50KSELL-13.97%86.22KMar 16View
Feb 25, 2016Sara BonsteinCHIEF FINANCIAL OFFICER-15.04K$5.58-$83.91KSELL-15.83%79.98KFeb 24View
Feb 01, 2016Petit RobertCHIEF SCIENTIFIC OFFICER-2.93K$6.85-$20.15KSELL-2.19%130.56KJan 29View
Feb 01, 2016Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.21K$6.85-$56.49KSELL-2.55%313.39KJan 29View
Dec 21, 2015Richard BermanDIRECTOR14.33K$12.39$177.57Ks20.45%84.43KDec 17View
Nov 03, 2015Petit RobertCHIEF SCIENTIFIC OFFICER-2.77K$11.66-$34.04KSELL-2.04%133.10KOct 30View
Nov 03, 2015Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.03K$11.65-$98.82KSELL-2.36%331.73KOct 30View
Oct 27, 2015Gregory MayesCHIEF OPERATING OFFICER-19.23K$11.63-$223.66KSELL-13.83%119.82KOct 26View
Oct 22, 2015David J MauroCHIEF MEDICAL OFFICER-24.59K$10.08-$247.83KSELL-12.90%165.93KOct 20View
Aug 24, 2015ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER300.00K$14.15$4.25MBUY5.32%5.94MAug 20 - Aug 24View
Aug 04, 2015Petit RobertCHIEF SCIENTIFIC OFFICER-2.85K$16.07-$43.81KSELL-2.06%135.59KJul 31View
Aug 04, 2015Daniel O'ConnorCHIEF EXECUTIVE OFFICER-8.13K$16.07-$125.20KSELL-2.34%338.86KJul 31View
May 04, 2015ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER500.00K$19.00$9.50MBUY9.73%5.64MApr 30View
Feb 20, 2015ADAGE CAPITAL PARTNERS GP LLCAdage Capital Partners LPAdage Capital Advisors LLCRobert AtchinsonPhillip Gross10% OWNER684.76K$7.50$5.14MBUY15.37%5.14MFeb 18View
May 09, 2014Richard BermanDIRECTOR-14.53K$2.63-$38.25KSELL-100.00%0.00May 09View
Apr 02, 2014Daniel O'ConnorCHIEF EXECUTIVE OFFICER3.33K$3.00$10.00KBUY1.08%311.02KMar 31View
Oct 29, 2013James P PattonDIRECTOR25.00K$4.00$100.00KBUY39.74%87.91KOct 24View
Oct 29, 2013Roni AppelDIRECTOR12.50K$4.00$50.00KBUY28.08%57.02KOct 24View
Oct 28, 2013Mark J RosenblumCHIEF FINANCIAL OFFICER12.00K$4.00$48.00KBUY110.07%22.90KOct 24View
Oct 28, 2013Robert PetitCHIEF SCIENTIFIC OFFICER12.80K$4.00$51.20KBUY282.00%17.34KOct 24View
Oct 28, 2013Daniel OConnorCHIEF EXECUTIVE OFFICER13.50K$4.00$54.00KBUY28.27%61.26KOct 24View
Jul 10, 2013Richard J BermanDIRECTOR1.14M$0.04-$24.76KGRANT168.05%1.82MNov 20 - Jun 12View
Feb 19, 2010Richard BermanDIRECTOR-760.62K$0.16-$121.70KSELL-100.00%0.00Feb 12View
Oct 30, 2007John F RothmanVP CLINICAL DEVELOPMENT61.04K$0.18$10.99KBUY28.43%275.77KOct 25View
Oct 30, 2007Fredrick D CobbVICE PRESIDENT FINANCE40.70K$0.18$7.33KBUY81.98%90.34KOct 25View
Oct 26, 2007Thomas A MooreCHAIRMAN / CEO2.67M$0.15$400.00KBUY∞2.67MOct 23View
Mar 01, 2007John RothmanVP CLINICAL DEVELOPMENT134.73K$0.16$21.56KBUY168.41%214.73KFeb 23View
Mar 01, 2007Fred D. CobbVICE PRESIDENT FINANCE49.64K$0.16$7.94KBUY∞49.64KFeb 23View
Jan 10, 2007Roni AppelDIRECTOR1.59M$0.20$311.60KBUY66.88%3.98MJan 25 - Jan 03View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved